Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by Mil_Man54on Oct 21, 2021 4:37pm
86 Views
Post# 34034718

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lets get real

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lets get realAcquisition through further dilution isn't progress...it's a setback for shareholders......spending $2.5M a year on marleting with nothing to market isn't progress....it's a setback.......look at the market reaction to all this "progress"......at best it's stagnant but we're still seeing losses......I'm wondering how many times Rosenberg used the word progress during the failed hydro grow op or during the FSD-201 failure......care to count them up for us Rosenberg.......if you want to know if there's progress or not.....look at the SP....

DavidRosenberg wrote:
Mil_Man54 wrote: What progress are you referring to Rosenberg....they acquired Lucid through further dilution of shares despite cash on hand....AD hired 6 marketing firms at a cost of over $200K a month....and they just signed an agreement with Covar were we have no relevant details of that agreement......so what exactly is the progress that should be generating gains right now.......and since it's the 4th time you've posted that link.....I'm sure everyone got it....pumper......

DavidRosenberg wrote:
Mil_Man54 wrote: Seems like you coverd everything pretty well this morning Jak.....and outstanding job putting Rosenberg in his place!!!!



That's all you care about ? lol 

How about progress with the company and generating gains as shareholders?

Anyways back to baby duties talk to you guys later

if you missed it check this out FSD Pharma Investor Deck 10-14-21.pdf | DocDroid

 



the progress of accuiring lucid psychecuticals was the first solid step but real results from clinical trials of the 2 drug compounds targetting major depression and MS will do the talking.

I want to know if there would be more acuisitions or thats it? time will tell 

good luck to the longs 


<< Previous
Bullboard Posts
Next >>